IPVM is moving to a 3-tier package/pricing structure, adding a new Info+ limited tier at the current $199 annual price while increasing the price of Info+ (unlimited) to $399 while increasing our output significantly.
Note: Existing active Info+ subscribers will be indefinitely grandfathered/kept on the Unlimited tier at existing lower pricing.
********, ***** ** ********** ** ****, will ****** **** *** **** *******, focusing ** *********** ******* *** ******** of ******** *** *********.
****+ ** ***** *********** ***** **** 2 ***** ** ***** *** * broad *** ***** ** *** ** those *********** ** ****+.
******* ************ ** ****: *** **** visible *********** **** **** ** **** we **** ********* ******** *** ****** of *********** ****** ***, ** **********, many ***** **** ************ ***** **** been ******* (*.*., **** *******) *** now ***** ****** ** ***********. *** plan **** ** **** ******** *** get ****** ** **** ** *** lowest ***** *****. *********** **** *** need ** **** ** **** ******* and *** ***** **** **, *** reports **** **, ** *******, ****** and **** ********.
********, **** ********* ******* ** ** add **** ********* ** ******** ***** and ********* ***** (*.*., ****** *** robotics), *** *** ***** **** **** to **** *** ****, ** *** incentivized ** ***** *** **** *** more *** ****+ *********.
****, **** ******* ******** ******* **** were ********* ** **** ** ******** will ** ***** ** ****+ ********* more *****, ***** *** ****** / longer ******** ******* ****** ********.
**********/*********: **** ***** ********* ****** ** many ****** ** ******** ** ******* from **** ***** ******** **** ***** who *** ******* ***** **** **** pay ******. **** ** ********** ******* our ******* * ****** ***, ** was **** * *** ********* *** much *****, ******* *****. *** **** far ******, *******, *** **** ******** posts, ** *** ******** * ***** pricing ********* *** *** **** ******.
Objections ** **** *********: While general objections to price are inevitable, as people have varying willingness to pay, the most specific objection we anticipate is the Info+ Limited structure of 10 Report reads per month, e.g. why can’t it be 15 or 20 Report reads per month or why can’t you do 120 Reports reads per year whenever you want?
** **** ******** *** *** ****+ Limited **** *** ***** *** **** want **** ** **** ******** ** what’s *** ******* ** **** ***** from **** ******** ****** (**** ******* manufacturer ***********) *** *** ******* “** already **** *** ******** **** *** we ** ***** ******* ******** ** some ** ****’* ****** ********* ** coverage *** ** ***’* **** *** want ** *** *** *** **** IPVM ******.” ******* ***+ *** *********** and ******* ******** *** ** ******** reports **** ****, ***** ** ***** we **** *******, ** *** ********* most **** *** ** **** ****.
*** ***** *** ****** **** *** flexibility *** ****** ** **** **** of ******* ******* ** ** *** given ****, ** ******* ** ** worth *** **** **** $*** *** most ** ***** ******, ***** *** unique ***** ******** ** ******* *** the ******* *** **** ** ***** IPVM *** ******** ** ************ ***.
Impact ** ******** ****** ***********
******** ****** ****+ *********** **** ** indefinitely *************/**** ** *** ********* **** at ******** ***** *******.
** **** ***** ** *** ******, not ****** **** *** ******** *****, at *** *** ** ************ ***** for ****** ************* (***+ *********), ** will *********** ****** $*** ********* ***** and *** ***** *********** ** **** $199 ********* ** $*** *********, ***.
*******
** *** ********* **** **** ** a ****** ********** *** ** ** deliver *** ****** *** ******* ****, benefiting *** *********** *** *** *****, while ***** ******** **** **** *** be ******** ** ***** **** ******* resources. ** **** ******* ** ********* as **** ** *** **** ****** as ** **** **** ** *** last.
* ***** **** ** * **** move.
*** ******* ****/******** ***** *** ********* a ***** **** **** *** *** unintended ****** ** ************* **** ** those *********** **** **** ************ **** IPVM *** ******* ** ** **** on ******** ********** ******* ******* (*)*** reports.
********* ** **/** - *** ***** this ****** **** **** ****** *** when *** ******* ***** *** ****... but **'* * ***** ********** ***** on ******** **** ****** ********* **** of **** ********** ******, ***.